| Phase 4 |
| NCT07606755 |
Clinical Efficacy Study of Jinfeng Pill in the Treatment of Perimenopausal Syndrome |
Perimenopausal Syndrome |
Recruiting |
2026-05-26 |
| NCT07028593 |
Effects of Ciprofol on Myocardial Injury After Non-cardiac Surgery in Video-Assisted… |
Myocardial Injury |
Recruiting |
2026-01-28 |
| NCT05303285 |
A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active… |
Ankylosing Spondylitis (AS) |
Recruiting |
2026-01-27 |
| NCT07077486 |
Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease |
Lupus or SLE |
Recruiting |
2026-01-27 |
| NCT07118579 |
Effects of Remimazolam and Ciprofol TIVA on PRAE in Pediatric Tonsillectomy and… |
Tonsillectomy With or Without Adenoidectomy |
Recruiting |
2025-11-21 |
| NCT06499233 |
Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in… |
Pneumonia, Pneumocystis |
Recruiting |
2024-10-01 |
| NCT06236022 |
The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi… |
Dilated Cardiomyopathy |
Recruiting |
2024-02-01 |
| NCT07452445 |
Efficacy and Safety of Ivarmacitinib Monotherapy in the Treatment of csDMARDs-IR… |
Rheumatoid Arthritis |
Not Yet Recruiting |
2026-03-05 |
| NCT05300932 |
A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis |
Systemic Sclerosis |
Active, Not Recruiting |
2026-01-27 |
| NCT07094945 |
The Effect of Remimazolam on Postoperative Sleep Quality |
Gynecological Day Surgery |
Not Yet Recruiting |
2025-07-31 |
| NCT06496815 |
Donafenib Combined With Immunotherapy and Local Therapy for Unresectable Hepatocellular… |
Unresectable Hepatocellular Carcinoma |
Not Yet Recruiting |
2024-07-11 |
| Phase 3 |
| NCT07002346 |
INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell… |
Ovarian Clear Cell Carcinoma |
Recruiting |
2026-05-18 |
| NCT06954584 |
Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line… |
Ovarian Cancer |
Recruiting |
2025-06-24 |
| NCT07537946 |
Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer |
Hepatocellular Carcinoma (HCC) |
Not Yet Recruiting |
2026-04-17 |
| NCT07288749 |
Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic… |
Type 2 Diabetes Mellitus (T2DM) |
Not Yet Recruiting |
2025-12-17 |
| NCT06990503 |
SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian Cancer |
Ovarian Cancer |
Not Yet Recruiting |
2025-05-25 |
| NCT06089369 |
Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion |
Hepatocellular Carcinoma |
Not Yet Recruiting |
2024-04-30 |
| NCT06089382 |
A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular… |
Hepatocellular Carcinoma |
Not Yet Recruiting |
2023-10-18 |
| Phase 2/3 |
| NCT06288373 |
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC |
Cervical Cancer |
Recruiting |
2024-10-30 |
| NCT05961202 |
The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy |
Inflammatory Cardiomyopathy |
Recruiting |
2024-10-09 |
| NCT07616271 |
Study on the Effect of Oral Diammonium Glycyrrhizinate in Attenuating Toxicity and… |
Patients With Large B-cell Lymphoma Receiving CAR-T Cell Therapy |
Not Yet Recruiting |
2026-06-01 |
| Phase 2 |
| NCT06954116 |
Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular… |
Resectable Hepatocellular Carcinoma With High Risk of Recurrence |
Recruiting |
2026-09-18 |
| NCT06187961 |
HAIC, Lenvatinib, and Cadonilimab as Conversion Therapy for Initially Unresectable… |
Hepatocellular Carcinoma Non-resectable |
Recruiting |
2026-08-26 |
| NCT06192797 |
Combined HAIC, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable… |
Cholangiocarcinoma Non-resectable |
Recruiting |
2026-07-22 |
| NCT07699185 |
Neoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally… |
Esophageal Squamous Cell Carcinoma |
Recruiting |
2026-07-13 |